Toxicity burden patterns of MET-selective tyrosine kinase inhibitors: evidence from real-world pharmacovigilance

作者：Wenjie Li, Wei Wang · 发表于：Investigational New Drugs · 年份：2024 · DOI：10.1007/s10637-024-01437-z · 被引用次数：5 · 研究领域：Melanoma and MAPK Pathways、Lung Cancer Treatments and Mutations、Advanced Breast Cancer Therapies